PMID: 2502627Aug 1, 1989Paper

Antibacterials. Synthesis and structure-activity studies of 3-aryl-2-oxooxazolidines. 1. The "B" group

Journal of Medicinal Chemistry
W A GregoryM Forbes

Abstract

The synthesis and structure/activity studies of the effect of varying the "B" group in a series of oxazolidinone antibacterials (I) are described. Two synthetic routes were used: (1) alkylation of aniline with glycidol followed by dialkyl carbonate heterocyclization to afford I (A = H, B = OH), whose arene ring was further elaborated by using electrophilic aromatic substitution methodology; (2) cycloaddition of substituted aryl isocyanates with epoxides to give A and B with a variety of values. I with B = OH or Br were converted to other "B" functionalities by using SN2 methodology. Antibacterial evaluation of compounds I with A = acetyl, isopropyl, methylthio, methylsulfinyl, methylsulfonyl, and sulfonamido and a variety of different "B" groups against Staphylococcus aureus and Enterococcus faecalis concluded that the compounds with B = aminoacyl, and particularly acetamido, were the most active of those examined in each A series, possessing MICs in the range of 0.5-4 micrograms/mL for the most active compounds described.

Citations

Nov 19, 2003·Bioorganic & Medicinal Chemistry Letters·Upinder SinghMikhail F Gordeev
Nov 19, 2003·Bioorganic & Medicinal Chemistry Letters·Michael B GravestockAlan Wookey
Nov 1, 2003·Bioorganic & Medicinal Chemistry Letters·Jae Seok LeeAe Nim Pae
May 24, 2005·Bioorganic & Medicinal Chemistry Letters·Prasad P DixitNeelima Sinha
Apr 18, 2002·Bioorganic & Medicinal Chemistry Letters·Du Yu, Guo Huiyuan
Jun 12, 2003·Bioorganic & Medicinal Chemistry Letters·Hye Yeon KimHun Yeong Koh
Jan 1, 1999·Bioorganic & Medicinal Chemistry Letters·D M GleaveC W Ford
May 2, 2002·Bioorganic & Medicinal Chemistry·Michele A Weidner-WellsDennis J Hlasta
Dec 7, 2002·Bioorganic & Medicinal Chemistry·O A PhillipsN Al-Hassawi
Feb 3, 2007·Chemical & Pharmaceutical Bulletin·Sunil Kumar Reddy AaramadakaMagesh Vijayan
Dec 1, 2015·ACS Medicinal Chemistry Letters·B SeetharamsinghD Srinivasa Reddy
Dec 24, 2011·Annals of the New York Academy of Sciences·Karen Joy Shaw, Michael R Barbachyn
Feb 14, 2015·Chemical Biology & Drug Design·Yan ChenWei-Min Chen
Sep 1, 2004·Il Farmaco·Alessandra AmmazzalorsoMaria L Tricca
Jul 1, 2004·Bioorganic & Medicinal Chemistry Letters·Sun-Young JangHyun-Joon Ha
Oct 20, 2009·Bioorganic & Medicinal Chemistry Letters·Vandana VarshneyDevi P Sahu
Oct 9, 2009·Bioorganic & Medicinal Chemistry Letters·Biswajit DasAnita Mehta
Dec 14, 2007·Bioorganic & Medicinal Chemistry·David C EbnerJ Thomas Ippoliti
Sep 20, 2016·MedChemComm·Jesse A JonesKirk E Hevener
Mar 24, 2016·Organic & Biomolecular Chemistry·Siva MurruRadhey S Srivastava
Jul 6, 2014·Angewandte Chemie·Peter M WrightAndrew G Myers
Oct 5, 2013·Clinical Microbiology Reviews·Michael J Pucci, Karen Bush
Jul 17, 2007·Chemical Biology & Drug Design·Jidong LiuWeicheng Zhou
Apr 4, 2008·Organic & Biomolecular Chemistry·David BensaRoger J Butlin
Oct 31, 2008·Organic & Biomolecular Chemistry·Yoshikazu HorinoYoshinao Tamaru
Jan 1, 1992·Journal of Enzyme Inhibition·C Z Ding, R B Silverman
Jan 26, 2016·Chemical Record : an Official Publication of the Chemical Society of Japan ... [et Al.]·Zheng-Jun Quan, Xi-Cun Wang
Feb 11, 2005·Chemical Reviews·Tariq A Mukhtar, Gerard D Wright
Jan 10, 2003·Journal of Medicinal Chemistry·Michael R BarbachynMichael A Wynalda

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.